Table 1.
Compound | EC50 (nM) | Fold-improvement over monovalent control (11 or 12) |
---|---|---|
SAM, 1 | 17.3 ± 0.3 | — |
11 | 120 ± 10 | — |
9a | 61 ± 3 | 2.0-fold |
9b | 37 ± 2 | 3.2-fold |
9c | 39 ± 1 | 3.1-fold |
9d | 75 ± 4 | 1.6-fold |
9e | 111 ± 5 | 1.1-fold |
12 | 36 ± 6 | — |
10a | 15 ± 5 | 2.4-fold |
10b | 10 ± 1 | 3.6-fold |
The concentration of the monovalent ligands 11 and 12 was 2 mM, and the concentration of the bivalent ligands 9 and 10 was 1 mM. The concentration of F-metC was 10 nM, and the final concentration of DMSO was 2%. EC50 values were determined based on an average of three titrations, fitted to a sigmoidal growth logistic model (see Supplementary data).